Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer
- MeSH Terms
- prostate, cancer, neoplasm, adenocarcinoma, carcinoma, malignancy, tumour, magnetic resonance imaging, magnetic resonance spectroscopy, dynamic, magnetic, diffusion weighted, nuclear magnetic resonance imaging, MRSI, DWI-MRI, DW-MRI, DCE-MRI, T1-weighted, T2-weighted
- Guideline Contact
- Xiaomei Yao; [email protected]
- Keywords
- prostate, cancer, neoplasm, magnetic resonance imaging, magnetic resonance spectroscopy, nuclear magnetic resonance imaging
- Date for Review
- In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
- Publication Date
- 2021-02-11
- Date of Last Evidence Search
- 2020-09-01
- Methods Applied
- Systematic review-based, Externally reviewed, Evidence quality assessment, GRADE approach
- Publication Scope
- diagnosis
- Guidelines
- Countries of Application
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- PEBC (Program in evidenced-based care)
- Publication Year
- 2021